Postpartum care of the woman with diabetes

Clinical Obstetrics and Gynecology

Volumn 43, Issue 1, 2000, Pages 75-86

  Kjos, Siri L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBODY; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR; CARBOHYDRATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; LEVONORGESTREL; LIPID; MEDROXYPROGESTERONE ACETATE; METFORMIN; NORETHISTERONE; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT; SULFONYLUREA DERIVATIVE; TROGLITAZONE;

CLINICAL TRIAL; CONTRACEPTION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET THERAPY; EXERCISE; FEMALE; FOLLOW UP; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LACTATION; LIFESTYLE; PATIENT COUNSELING; PATIENT EDUCATION; PREGNANCY DIABETES MELLITUS; PUERPERIUM; REVIEW;

BLOOD GLUCOSE SELF-MONITORING; CONTRACEPTION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DIABETIC DIET; FEMALE; HUMANS; LACTATION; LIFE STYLE; PATIENT EDUCATION; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 0034125334     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200003000-00008     Document Type: Review

References (90)

1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1999;22(Suppl 1):S2-S5.
2. Metzger BE, ed. Summary and recommendations of the 4th International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 1998;21(Suppl 2): B161-B167.
3. American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care. 1999;22(Suppl 1):S74-S76.
4. Ferris AM, Neubauer SH, Bendel RB, Green KW, Ingardia CJ, Reece EA. Perinatal lactation protocol and outcome in mothers with and without insulin-dependent diabetes mellitus. Am J Clin Nutrit. 1993;58: 43-48.
5. Lammi-Keefe CJ, Jonas CR, Ferris AM, Capacchione CM. Vitamin E in plasma and milk of lactating women with insulin-dependent diabetes mellitus. J Ped Gastroent Nutrit. 1995;20:305-309.
6. Neubauer SH, Ferris AM, Chanse CG, et al. Delayed lactogenesis in women with insulin-dependent diabetes mellitus. Am J Clinic Nutrit. 1993;58:54-60.
7. Ferris AM, Dalidowitz CK, Ingrdia DM, et al. Lactation outcome in insulin-dependent diabetic women. J Am Dietetic Assoc. 1988;88:317-322.
8. Kjos SL, Henry O, Lee RM, Buchanan TA, Mishell DR, Jr. The effect of lactation on glucose and lipid metabolism in women with recent gestational diabetes. Obstet Gynecol. 1993;82:451-455.
9. Anonymous. The effect of intensive therapy of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329: 977-986.
10. Anonymous. United Kingdom Prospective Diabetes Study 24: A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med. 1998;128:165-175.
11. American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study: Reviews/commentaries/ position statement: Position Statement. Diabetes Care. 1998;21:2180-2184.
12. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared to conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
13. UK Prospective Diabetes Study Group. Intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
14. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. (UKPDS 38). BMJ. 1998;317:703-713.
15. O'Sullivan JB. Diabetes after GDM. Diabetes. 1991;40(Suppl 2):131-135.
16. Mestman JH, Anderson GV, and Guadalupe V. Follow-up studies of 360 subjects with abnormal carbohydrate metabolism during pregnancy. Obstet Gynecol. 1972; 39:421-425.
17. Henry OA, Bleischer NA. Long-term implications of gestational diabetes for the mother. Ballieres Clin Obstet Gynaecol. 1991;5:461-83.
18. Persson B, Hanson U, Hartling SG, Binder C. Follow-up of women with previous GDM: Insulin, C-peptide, and proinsulin responses to oral glucose load. Diabetes. 1991;40(Suppl 2):136-141.
19. Damm P, Kuhl C, Bertelsen A, Molsted-Pedersen L. Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol. 1992;167:607-616.
20. Metzger BE, Cho NH, Roston SM, Rodvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care. 1993;16:1598-1605.
21. Coustan DR, Carpenter MW, O'Sullivan PS, Carr SR. Gestational diabetes: Predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol. 1993;168: 1139-1145.
22. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro MN, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes: Utility of early postpartum glucose tolerance testing. Diabetes. 1995; 44:586-591.
23. Freinkel N, Metzger BE, Phelps RL, et al. Gestational diabetes mellitus: Heterogeneity of maternal age, weight, insulin secretion, HLA antigens, and islet cell antibodies and the impact of maternal metabolism on pancreatic β-cell function and somatic growth in the offspring. Diabetes. 1985; 34(Suppl 2):1-7.
24. Catalano PM, Tyzbir ED, Sims EAH. Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care. 1990;13:478-482.
25. Steele JM, Irvine WJ, Clarke BF. The significance of pancreatic islet cell antibody and abnormal glucose tolerance during pregnancy. J Clin Lab Med. 1980;4:83-85.
26. Damm P, Kuhl C, Buschard K, et al. Prevalence and predictive value of islet cell antibodies and insulin autoantibodies in women with gestational diabetes. Diabet Med. 1994;11:558-563.
27. Mauricio D, Balsells M, Morales J, Corcoy R, Puig-Domingo M, de Levia A. Islet cell autoimmunity in women with gestational diabetes and risk of progression to insulin-dependent diabetes mellitus. Diab Metab Rev. 1996;12:275-285.
28. Petersen JS, Dyrberg T, Damm P, Kuhl C, Molsted-Pedersen L, Buschard K. GAD65 autoantibodies in women with gestational or insulin-dependent diabetes mellitus during pregnancy. Diabetologia. 1996;39:1329-1333.
29. O'Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 1964;13:278-285.
30. Kjos SL, Buchanan TA, Greenspoon JS, Montoro M, Bernstein GS, Mestman JH. Gestational diabetes mellitus: The prevalence of glucose intolerance and diabetes mellitus in the first two months postpartum. Am J Obstet Gynecol. 1990;163:93-98.
31. O'Sullivan JB. Gestational diabetes: Factors influencing the rates of subsequent diabetes. In: Sutherland HW, Stowers JM, eds. Carbohydrate Metabolism in Pregnancy and the Newborn. Berlin: Springer Verlag, 1979:425-435.
32. Catalano PM, Vargo KM, Bernstein IM, Amini SB. Incidence and risk factors associated with abnormal glucose postpartum tolerance in women with gestational diabetes. Am J Obstet Gynecol. 1991;165:914-919.
33. Yen SCC, Tsai CC, Vela P. Gestational diabetogenesis: Quantitative analysis of glucose-insulin interrelationship between normal pregnancy and pregnancy with gestational diabetes. Am J Obstet Gynecol. 1971;111:792-800.
34. Kuhl C, Holst JJ. Plasma glucagon and then insulin:Glucagon ratio in gestational diabetes. Diabetes. 1976;25:16-23.
35. Fisher PM, Sutherland HW, Bewsher PD. The insulin response to glucose infusion in gestational diabetes. Diabetologia. 1980;19: 10-14.
36. Buchanan TA, Metzger BE, Freinkel N, Bergman RN. Insulin sensitivity and β-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol. 1990;162:1008-1014.
37. Catalano PM, Tzyzbir ED, Wolfe RR, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol. 1993; 264:E60-E67.
38. Xiang AH, Peters RK, Trigo E, Kjos SL, Lee WP, Buchanan TA. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes. 1999;48:848-854.
39. Lindsay CA, Huston L, Amini SB, Catalano PM. Longitudinal changes in the relationship between body mass index and percent body fat in pregnancy. Obstet Gynecol. 1997;89:377-382.
40. Ward WK, Johnston CLW, Beard JC, Benedetti TJ, Porte D. Abnormalities of islet β-cell function, insulin action and fat distribution in women with a history of gestational diabetes: Relation to obesity. J Clin Endocrinol Metab. 1985;61:1039-1045.
41. Ward WK, Johnston, CLW, Beard JC, Benedetti TJ, Halter JB, Porte D. Insulin resistance and impaired insulin secretion in subjects with a history of gestational diabetes mellitus. Diabetes. 1985;34:861-869.
42. Catalano PM, Bernstein IM, Wolfe RR, Srikanta S, Tyzbir E, Sims EAH. Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes. Am J Obstet Gynecol. 1986;155:1255-1262.
43. Damm P, Vestergaard H, Kuhl C, Pedersen O. Impaired insulin-stimulated nonoxidative glucose metabolism in glucose-tolerant women with previous gestational diabetes. Am J Obstet Gynecol. 1996;174:722-729.
44. Ryan EA, Imes S, Liu D, McManus R, Finegood DT, Polonsky KS, Sturis J. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes. 1995;44:506-512.
45. Kautzky-Willer A, Prager R, Waldhausl W, et al. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care. 1997;20:1717-1723.
46. Peters RK, Kjos SL, Xiang A, Buchanan TA. Long-term diabetogenic effect of a single pregnancy in women with prior gestational diabetes mellitus. Lancet. 1996;347: 227-230.
47. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 1999;22(Suppl 2): S32-S41.
48. Fuhrmann K, Reiher H, Semmler K, et al. The effect of intensified conventional insulin therapy before and during pregnancy on the malformation rate in offspring of diabetic mothers. Exp Clin Endocrinol. 1984; 83:173-177.
49. Mills JL, Baker L, Goldman AS. Malformations in infants of diabetic mothers occur before the seventh gestational week. Diabetes. 1979;28:292-293.
50. Towner D, Kjos SL, Leung B, et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care. 1995; 18:1446-1451.
51. Schaefer UM, Songster G, Xiang A, Berkowitz K, Buchanan TA, Kjos SL. Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstet Gynecol. 1997;177:1165-1171.
52. Trussel J, Hatcher RA, Cates W, Stewart FH, Kost K. Contraceptive failure in the United States: An update. Studies in Family Planning. 1990;21:51-54.
53. Radberg T, Gustafson A, Skryten A, et al. Oral contraception in diabetic women. Diabetes control, serum and high-density lipoprotein lipids during low-dose progestogen, combined estrogen/progestogen and nonhormonal contraception. Acta Endocrinol. 1981;98:246-251.
54. Skouby SO, Jensen BM, Kuhl C, et al. Hormonal contraception in diabetic women: Acceptability and influence on diabetes control and ovarian function of a nonalkylated estrogen/progestogen compound. Contraception. 1985;32:23-31.
55. Peterson KR, Skouby SO, Sidelmann J, Molsted-Pedersen L, Jespersen J. Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus. Am J Obstet Gynecol. 1994;171:400-405.
56. Petersen KR, Skouby SO, Sidelmann J, Jespersen J. Assessment of endothelial function during oral contraception in women with insulin-dependent diabetes mellitus. Metabolism. 1994;43:1379-1383.
57. Klein BEK, Moss SE, Klein R. Oral contraceptives in women with diabetes. Diabetes Care. 1990;13:895-898.
58. Garg SK, Chase HP, Marshal G, Hoops S, Holmes DL, Jackson WE. Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus. JAMA. 1994;271:1099-1102.
59. Skouby SO, Kuhl C, Molsted-Pedersen L, et al. Triphasic oral contraception: Metabolic effects in normal women and those with previous gestational diabetes; Am Obstet Gynecol. 1985;153:495-500.
60. Skouby SO, Anderson O, Saurbrey N, et al. Oral contraception and insulin sensitivity: In vivo assessment in normal women and women with previous gestational diabetes. J Clin Endocrinol Metab. 1987;64:519-523.
61. Kjos SL, Shoupe D, Douyan S, et al. Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study; Am J Obstet Gynecol. 1990;163:1822-1827.
62. Kjos SL, Peters RK, Xiang A, Thomas D, Schaefer U, Buchanan TA. Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA. 1998;280:533-538.
63. Kjos SL. Contraception in diabetic women. Obstet Gynecol Clin North Am. 1996;23: 243-258.
64. Anonymous. National Cholesterol Education Project. Second report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Circulation. 1994;89:1333-1445.
65. Fahmy K, Abdel-Razik, Shaaraway M, et al. Effect of long-acting progestaten-only injectable contraceptives on carbohydrate metabolism and its hormonal profile. Contraception. 1991;44:419-429.
66. Konje JC, Otolorin EO, Ladipo AO. The effect of continuous subdermal levonorgestrel (Norplant) on carbohydrate metabolism. Am J Obstet Gynecol. 1992;166:15-19.
67. Singh K, Viegas OA, Koh SC, Ratnam SS. The effect of long-term use of Norplant implants on hemostatic function. Contraception. 1992;45:141-153.
68. Farley TMM, Rosenberg MJ, Rowe PJ, Chen J-H, Meirek O. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet. 1992;339: 785-788.
69. Skouby SO, Molsted-Pedersen L, Kosonen A. Consequences of intrauterine contraception in diabetic women. Fertil Steril. 1984; 42:568-572.
70. Kimmerle R, Weiss R, Berger M, Kurz K-H. Effectiveness, safety, and acceptability of a copper intrauterine device (CU Safe 300) in type I diabetic women. Diabetes Care. 1993;16:1227-1230.
71. Kjos SL, Ballagh SA, La Cour M, Xiang A, Mishell DR, Jr. The copper T380A intrauterine device in women with type II diabetes mellitus. Obstet Gynecol. 1994;84: 1006-1009.
72. Berkowitz K, Peters R, Kjos SL, et al. Effect of troglitazone on insulin sensitivity and pancreatic β-cell function in women at high risk for NIDDM. Diabetes. 1996;45: 1572-1579.
73. Anonymous. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999;22:623-634.
74. American Diabetes Association. Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care. 1999;22(Suppl 1):S42-S45.
75. American Diabetes Association. Diabetes mellitus and exercise. Diabetes Care. 1999; 22(Suppl 1):S49-S53.
76. Usui K, Yamanouchi K, Asai K, et al. The effect of low intensity bicycle exercise on insulin-induced glucose uptake in obese patients with type 2 diabetes. Diabetes Res Clin Pract. 1998;41:57-61.
77. Giacca A, Groenewoud Y, Tsui E, McClean P, Zinman B. Glucose production, utilization, and cycling in response to moderate exercise in obese subjects with type 2 diabetes and mild hyperglycemia. Diabetes. 1998;47:1763-1770.
78. Halle M, Berg A, Garwers U, et al. Influence of 4 weeks intervention by exercise and diet on low-density lipoprotein subfractions in obese men with type 2 diabetes. Metabolism. 1999;48:641-644.
79. Dunstan DW, Mori TA, Puddley IB, et al. A randomized, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics. Thromb Haemost. 1999;81:367-372.
80. Eriksson KF, Lindegarde F. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise. Diabetologia. 1998;41:1010-1016.
81. Pan X-R, Li G-W, Hu Y-H, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-544.
82. Gregory KD, Kjos SL, Peters RK. Cost of noninsulin-dependent diabetes in women with a history of gestational diabetes: Implications for prevention. Obstet Gynecol. 1993;81:782-786.
83. Pettitt DJ, Baird HR, Aleck KA, Bennett PH Knowler WC. Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med. 1983; 308:242-245.
84. Pettitt DJ, Bennett PH, Knowler WC, Baird HR, Aleck KA. Gestational diabetes mellitus and impaired glucose tolerance during pregnancy: Long-term effects on obesity and glucose tolerance in the offspring. Diabetes. 1985;34(Suppl 2):119-122.
85. Pettitt DJ, Knowler WC. Long-term effects of the intrauterine environment, birth weight, and breastfeeding on Pima Indians. Diabetes Care. 1998;21(Suppl 2):B138-B141.
86. Silverman BL, Rizzo T, Green OC, et al. Long-term prospective evaluation of offspring of diabetic mothers. Diabetes. 1991; 40(Suppl 2):121-125.
87. Silverman BL, Rizzo TA, Cho NH, Metzger BE. Long-term effects of the intrauterine environment. Diabetes Care. 1998;21(Suppl 2): B142-B149.
88. Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS. Physical activity and reduced occurrence of noninsulin-dependent diabetes. N Engl J Med. 1991;325:147-152.
89. Manson JE, Rimm EB, Stampfer MJ, et al. Physical activity and incidence of noninsulin-dependent diabetes mellitus in women. Lancet. 1991;338:774-778.
90. U.S. Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. Washington, DC: U.S. Government Printing Office, 1996.